Blog
RSS FeedPosted by Michael Wonder on 18 May 2020
International reference pricing gets thumbs down from ISPOR panel
18 May 2020 - International reference pricing, by which drug prices would be pegged to international standards, is under consideration ...
Posted by Michael Wonder on 12 May 2020
A comparison of the EQ-5D-3L and EQ-5D-5L
12 May 2020 - Previous studies have found the EQ-5D-5L to have superior measurement properties but no study has compared ...
Posted by Michael Wonder on 09 Jan 2020
U.S. health care system costs four times more to run than Canada’s single payer system
7 January 2020 - In the United States, a legion of administrative health care workers and health insurance employees who ...
Posted by Michael Wonder on 30 Nov 2019
Performance of UK National Health Service compared with other high income countries: observational study
27 November 2019 - The UK’s spending on health care has been constrained for some time, with slow growth in spending ...
Posted by Michael Wonder on 25 Nov 2019
Medicine prices in Australia among the cheapest in the world, research shows
25 November 2019 - If you take medication for several health issues, you may be surprised to find out Australia has ...
Posted by Michael Wonder on 03 Nov 2019
International impact of external reference pricing: should national policy makers care?
3 November 2019 - External reference pricing is widely used to regulate drug prices. ...
Posted by Michael Wonder on 26 Oct 2019
Real-time benefit tools for drug prices
25 October 2019 - Concerns over drug prices and medication nonadherence have led to a search for new strategies to lower ...
Posted by Michael Wonder on 21 Oct 2019
International pricing index ‘accomplishes nothing it sets out to do’
21 October 2019 - Even with all of the political chatter in Washington, D.C., talk about controlling prescription drug prices ...
Posted by Michael Wonder on 01 Oct 2019
Variation in prescription drug prices by retail pharmacy type: a national cross-sectional study
1 October 2019 - Cash prices for prescription drugs vary widely in the United States. ...
Posted by Michael Wonder on 12 Aug 2019
New Zealand's access to funded medicines 'well behind the rest of the world'
12 August 2019 - New Zealand has the worst access to funded modern medicines of 20 OECD countries, a report ...
Posted by Michael Wonder on 14 Jul 2019
Bev takes 14 pills a day. She's far from alone.
15 July 2019 - She is among the more than one-in-three Australians aged over 70 who take five or more different ...
Posted by Michael Wonder on 09 Jul 2019
CMS’s international pricing model for Medicare Part B drugs: implementation issues
9 July 2019 - For many years, Americans have paid significantly more than the rest of the world for prescription drugs. ...
Posted by Michael Wonder on 17 Jun 2019
Population adjustment methods for indirect comparisons: A review of NICE Technology Appraisals
13 June 2019 - Indirect comparisons via a common comparator (anchored comparisons) are commonly used in health technology assessment. However, ...
Posted by Michael Wonder on 18 Feb 2019
Hospital drug prices are up to 7 times greater than Medicare pricing
15 February 2019 - A new study shows something many healthcare patients know all too well: hospitals are charging significant ...
Posted by Michael Wonder on 08 Feb 2019
What is driving HTA decision-making? Evidence from cancer drug reimbursement decisions from 6 European countries.
7 February 2019 - Decisions on the reimbursement of the same cancer drugs are different across European countries, but empirical work ...